-+ 0.00%
-+ 0.00%
-+ 0.00%

MEGAPRO <6827.TWO> SAYS CO SUBMITS APPLICATION TO U.S. FDA TO CONDUCT PHASE III CLINICAL TRIAL ON NEW DRUG MPB-1523

Reuters·09/09/2026 08:04:06

Please log in to view news